Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
269.40    1.20 (0.45%)
Bid:
269.30
Ask:
269.40
Spread: 0.10 (0.037%)
Market Cap: £14.78b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Director/PDMR Shareholding

10 Apr 2026 18:15

RNS Number : 0581A
Legal & General Group Plc
10 April 2026
Β 

Legal & General Group Plc

Β 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated

Β 

The following notification made under article 19 of the UK Market Abuse Regulation ("UK MAR") relates to the vesting of restricted shares awarded on 8 April 2025.

Β 

The first tranche of this award vested on 8 April 2026 and were released under the terms of The Legal & General Group Share Bonus Plan ("SBP") in respect of the PDMR below. Further tranches of this award are due to vest on 8 April 2027 and 8 April 2028.

Β 

Under the plan provisions, the default of selling sufficient shares to cover tax liabilities and retention of the remaining shares is applied.

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Katie Worgan

2

Reason for the notification

a)

Position/status

Group Chief Operating Officer/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Legal & General Group Plc

b)

LEI

213800JH9QQWHLO99821

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of Β£0.025 each, with voting rights attached.

Β GB0005603997

b)

Nature of transaction

1. Vesting of restricted share award of 35,555 shares.

2. Sale of 16,757 shares to cover tax and national insurance. The balance of 18,798 shares retained.

Β 

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

1. Nil

1. 35,555

2. Β£2.633

2. 16,757

d)

Aggregated information

- Aggregated volume

- Price

1. Price

1. Volume

1. Total

1. Nil

1. 35,555

Β 

1. Nil

2. Price

2. Volume

2. Total

2. Β£2.633

2. 16,757

2. Β£44,116.44

e)

Date of the transaction

8 April 2026

f)

Place of the transaction

London Stock Exchange, XLON

Β 

Β 

Β 

10 April 2026

Β 

Leanne Cornish

Deputy Group Company Secretary

Legal & General Group Plc

Tel: 020 3124 4111

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEBLFFQZLLBBF
Date   Source Headline
21st Mar 20249:00 amRNSDirector/PDMR Shareholding
13th Mar 202410:30 amRNSAnnual Financial Report
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 2
6th Mar 20247:00 amRNSL&G Full Year Results 2023 Part 1
4th Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSDirector/PDMR Shareholding
1st Mar 20245:00 pmRNSTotal Voting Rights
27th Feb 20249:00 amRNSChange of Group Remuneration Committee Chair
23rd Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20245:00 pmRNSDirector Declaration
2nd Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSTotal Voting Rights
1st Feb 20245:00 pmRNSDirector/PDMR Shareholding
1st Feb 20245:00 pmRNSDirector/PDMR Shareholding
5th Jan 20245:00 pmRNSBlock listing Interim Review
3rd Jan 20245:00 pmRNSDirector/PDMR Shareholding
4th Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSDirector/PDMR Shareholding
1st Dec 20235:00 pmRNSTotal Voting Rights
1st Dec 20235:00 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSL&G agrees full buy-in for Boots Pension Scheme
9th Nov 20239:00 amRNSDirector Declaration
2nd Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSDirector/PDMR Shareholding
1st Nov 20235:00 pmRNSTotal Voting Rights
3rd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20235:00 pmRNSTotal Voting Rights
28th Sep 20235:00 pmRNSDirector/PDMR Shareholding
28th Sep 20235:00 pmRNSDirector Declaration
28th Sep 20235:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:00 amRNSChange of Senior Independent Director
4th Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSTotal Voting Rights
1st Sep 20235:00 pmRNSDirector/PDMR Shareholding
1st Sep 20235:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSL&G Half Year Results 2023 Part 2
15th Aug 20237:00 amRNSL&G Half Year Results 2023 Part 1
2nd Aug 20235:00 pmRNSDirector/PDMR Shareholding
1st Aug 20235:00 pmRNSDirector/PDMR Shareholding
1st Aug 20235:00 pmRNSDirector/PDMR Shareholding
1st Aug 20235:00 pmRNSTotal Voting Rights
21st Jul 20235:53 pmRNSHolding(s) in Company
5th Jul 20237:00 amRNSIFRS 17 Transition Update
4th Jul 20235:01 pmRNSDirector/PDMR Shareholding
3rd Jul 20235:00 pmRNSBlock listing Interim Review
3rd Jul 20235:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.